MRI could tell doctors if chemo is working after just one dose
NCT ID NCT07202845
Summary
This study aims to see if special MRI scans taken early in chemotherapy treatment can predict whether a patient's muscle-invasive bladder cancer will respond. Researchers will scan 39 patients before treatment, 24 hours after their first chemotherapy dose, and after completing chemo, then compare the scans to surgical results. The goal is to identify patients who won't benefit from chemo early, so they can avoid unnecessary side effects and delays to surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIBC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amr E. Darwish
RECRUITINGAsyut, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.